Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Paxil class action

Executive Summary

Plaintiffs claiming Paxil is habit-forming will resubmit motion for class action certification after Los Angeles district court denied certification request Jan. 10, citing viability concerns for multi-state action. The court earlier denied the plaintiff's request to enjoin GSK from airing ads with "Paxil is non-habit forming" claim (1"The Pink Sheet" Aug. 26, 2002, p. 21)...
Advertisement

Related Content

Paxil TV Ad Case Could Produce Ruling On FDA’s Authority To Regulate Ads
Paxil TV Ad Case Could Produce Ruling On FDA’s Authority To Regulate Ads
Advertisement
UsernamePublicRestriction

Register

PS041137

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel